By admin 
Evertz Pharma GmbH, an organization specializing in premium pure cosmetics, has become Germany’s first firm to undertake a strategic Bitcoin reserve mannequin by buying a further 100 BTC in Could 2025—valued at roughly €10 million (~$10.8 million USD), in response to a press launch.
The adoption marks a continued enlargement of the corporate’s BTC treasury, which started in December 2020 with an preliminary €2 million Bitcoin purchase. Since then, Evertz Pharma has often allotted company income towards Bitcoin, constructing a digital reserve aimed toward long run stability.
“Our mission is to advertise pure magnificence on a scientific basis,” mentioned Dominik Evertz, Managing Director of Evertz Pharma GmbH. “The identical future-focused mindset shapes our monetary technique: Bitcoin, as a scarce and globally tradable asset, enhances our reserves and strengthens the long-term resilience of our firm.”
The corporate’s newest acquisition of 100 BTC distinguishes it from trade friends and conventional treasury methods. Tobias Evertz, Group CFO said, “We’ll proceed to speculate company income in Bitcoin and are continuously evaluating extra methods to extend our holdings sustainably.”
Not like publicly traded Bitcoin adopters resembling Technique or Metaplanet, Evertz Pharma operates as a privately held German enterprise.
“Bitcoin isn’t just an funding for us however a strategic asset that completely enhances our imaginative and prescient of stability and future resilience. On the similar time, we’re aligning our monetary technique with the wants of a contemporary, sustainably working firm,” added Dominik Evertz.
Everetz explains that Bitcoin is a retailer of worth, a hedge in opposition to inflation, and a method to diversify reserves. It permits Evertz Pharma to protect capital with out the storage burdens that include conventional belongings like gold. The corporate’s treasury technique exhibits their dedication to monetary sustainability.